Recombinomics | Elegant Evolution






Home Founder What's New In The News Contact Us





























Paradigm Shift

Viral Evolution

Intervention Monitoring

Vaccine Screening

Vaccine Development

Expression Profiling

Drug Discovery

Custom Therapies

Patents



Commentary

Recombinomics Paper Available at Nature Precedings
Recombinomics Commentary
July 12, 2007


Recombinomics has begun submitting papers to Nature's new site, Nature Precedings.  The site allows papers to be viewed by the scientific community, if accepted by Nature's professional curators.

The site also allows for comments and voting (both require log in after registration, which is free).  Thus, the papers are "open access".  No Nature subscription is required to download the papers (or vote or comment).

Recombinomics' first paper, "Swine Influenza A Evolution via Recombination - Genetic Drift Reservoir" is available at Nature (where it can be downloaded).  Votes and comments can also be viewed.

In the next few weeks, Recombinomics will be submitting a number of papers on recombination, which will conclusively demonstrate the role of recombination in influenza evolution.  These papers will significantly impact the two basic tenets of influenza genetics, drift via "random mutation" and shift via reassortment.

These papers will be submitted to Nature Precedings, and if accepted, they will also be linked on the Recombinomics’ publication page.  Included in the new submissions will be the concurrent detection of NA G743A in three countries, Russia, Egypt, and Ghana.  This polymorphism was appended onto six different genetic backgrounds, which is difficult to explain by “random mutations”.

Recombination involving acquisition of H5N1 sequences from migratory birds, and appending the polymorphisms onto resident H5N1 genetic backgrounds straightforwardly explains the data. The polymorphism tracing used to identify this change, as well as others, including the changes in or near the HA receptor binding domain, V223I and M230I, can be used to develop vaccine targets in advance of the detection of the polymorphisms on new genetic backgrounds.

Media Sources

Recombinomics Presentations

Recombinomics Publications

Recombinomics' Paper at Nature Precedings















Home | Founder | What's New | In The News | Contact Us

Webmaster: webmaster@recombinomics.com
© 2007 Recombinomics.  All rights reserved.